The technology, which in the past had been limited by size and cost, provides targeted doses of radiation to tumors, ...

Prevent Cancer Foundation's 2025 Early Detection Survey showed that only about half of U.S. adults 21 years and older said ...

director of the pediatric and young adult cancer cell therapy program at Dana-Farber Cancer Institute and Boston Children’s Hospital. Gavin’s parents started him on radiation. For 30 days ...

Seeing Jentai Otremba as a thriving sophomore in college at the University of Minnesota has been a full-circle moment for ...

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) on Monday released topline results from the pivotal Phase 3 TRANSCEND trial ...

performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high-grade glioma. They found that the drug, already FDA-approved for ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever ...

In order to ensure high-end patient care and meet the needs of various departments, advanced medical equipment worth Rs 50 ...

One of the most common side effects of cancer treatments, including chemotherapy and radiation therapy, is fatigue.

The radiation risk of Technetium Tc 99m pentetate is greater in pediatric patients than adults ... and of concomitant disease ...